文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

不同脓毒症风险分层工具在普通病房和急诊科的应用揭示不同死亡风险:三项威尔士全国多中心现患率研究结果

The Use of Different Sepsis Risk Stratification Tools on the Wards and in Emergency Departments Uncovers Different Mortality Risks: Results of the Three Welsh National Multicenter Point-Prevalence Studies.
PubMed 文献 · Crit Care Explor · 2021-10-21
一句话结论现行脓毒症风险分层工具在急诊和普通病房均不能准确预测90天死亡,SOFA和NICE工具对7天和14天死亡仅中等区分度。

该研究为三项年度24小时现患率研究的二次分析,覆盖威尔士14家急性医院的普通病房和急诊科,共纳入1271例患者。其中56.9%符合SIRS≥2,53.4%符合SOFA≥2,76.9%符合Red Flag Sepsis;按NICE指南分层,35.4%为高风险、52.3%为中高风险、12.3%为低风险。计划敏感性分析显示,所有工具均不能准确预测90天死亡,SOFA和NICE工具对7天和14天死亡仅中等区分度,且各工具在任何死亡时间点均无显著相关性。结论提示当前用于急诊和普通病房的脓毒症风险分层工具不能充分预测死亡。

要点

  • 在1271例急诊和普通病房患者中,SOFA≥2占53.4%,SIRS≥2占56.9%,Red Flag Sepsis占76.9%,各工具捕获人群差异大。
  • 按NICE指南分层,高风险占35.4%,中高风险占52.3%,低风险占12.3%,但各层死亡风险存在差异且工具间一致性弱。
  • 计划敏感性分析显示,SOFA和NICE工具对7天和14天死亡仅中等区分度,对90天死亡均不能准确预测。
  • 各工具在任何死亡时间点均未显示显著相关性,提示现行风险分层工具在急诊和普通病房的预测效能不足。
  • 未来脓毒症识别工具开发应同时关注短期和长期结局的预测价值。

适用人群与场景

  • 排除人群原文未提及。

诊断标准与关键阈值

  • SOFA评分≥2、SIRS标准≥2项、Red Flag Sepsis标准、NICE脓毒症风险分层(高风险、中高风险、低风险)。
  • 原文未提及各工具的具体诊断界值细节或启动/停止阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:三项年度24小时现患率研究的二次分析;样本量1271例,中心数14家急性医院;人群为急诊科和普通病房患者。
  • 干预/对照:无干预,比较SOFA、SIRS、Red Flag Sepsis和NICE风险分层工具的性能。
  • 主要终点结果:所有工具均不能准确预测90天死亡;SOFA和NICE工具对7天和14天死亡仅中等区分度;各工具在任何死亡时间点均无显著相关性。
  • 关键次要终点:SIRS≥2占56.9%(724/1271),SOFA≥2占53.4%(679/1271),Red Flag Sepsis占76.9%(977/1271);NICE分层高风险35.4%(450/1271)、中高风险52.3%(665/1271)、低风险12.3%(156/1271)。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:现患率研究的二次分析(观察性研究)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:原文未明确列出局限;设计本身为观察性、无干预、仅三个24小时横断面、单国家多中心。

对床旁实践的改变

  • 提示急诊和普通病房不应单独依赖SOFA、SIRS、Red Flag Sepsis或NICE分层工具来准确预测脓毒症患者死亡风险。
  • 各工具捕获的人群死亡风险存在差异且一致性弱,临床决策需结合其他信息,不能仅凭工具分层判断预后。
  • 未来工具开发应同时关注短期和长期结局的预测价值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the performance of Sequential Organ Failure Assessment, systemic inflammatory response syndrome, Red Flag Sepsis, and National Institute of Clinical Excellence sepsis risk stratification tools in the identification of patients at greatest risk of mortality from sepsis in nonintensive care environments.

DESIGN: Secondary analysis of three annual 24-hour point-prevalence study periods.

SETTING: The general wards and emergency departments of 14 acute hospitals across Wales. Studies were conducted on the third Wednesday of October in 2017, 2018, and 2019.

PATIENTS: We screened all patients presenting to the emergency department and on the general wards.

MEASUREMENTS AND MAIN RESULTS: We recruited 1,271 patients, of which 724 (56.9%) had systemic inflammatory response syndrome greater than or equal to 2, 679 (53.4%) had Sequential Organ Failure Assessment greater than or equal to 2, and 977 (76.9%) had Red Flag Sepsis. When stratified according to National Institute of Clinical Excellence guidelines, 450 patients (35.4%) were in the "High risk" category in comparison with 665 (52.3%) in "Moderate to High risk" and 156 (12.3%) in "Low risk" category. In a planned sensitivity analysis, we found that none of the tools accurately predicted mortality at 90 days, and Sequential Organ Failure Assessment and National Institute of Clinical Excellence tools showed only moderate discriminatory power for mortality at 7 and 14 days. Furthermore, we could not find any significant correlation with any of the tools at any of the mortality time points.

CONCLUSIONS: Our data suggest that the sepsis risk stratification tools currently utilized in emergency departments and on the general wards do not predict mortality adequately. This is illustrated by the disparity in mortality risk of the populations captured by each instrument, as well as the weak concordance between them. We propose that future studies on the development of sepsis identification tools should focus on identifying predicator values of both the short- and long-term outcomes of sepsis.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Unwin HJA, Kopczynska M, Pugh R, et al. The Use of Different Sepsis Risk Stratification Tools on the Wards and in Emergency Departments Uncovers Different Mortality Risks: Results of the Three Welsh National Multicenter Point-Prevalence Studies. Crit Care Explor. 2021. PMID: 34704060. doi:10.1097/CCE.0000000000000558

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。